Pfizer, one of the world’s biggest pharmaceutical companies announced a partnership with Mainz, Germany based BioNTech, to co-develop and distribute (excluding China) a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The company’s...
Harvard and Merck will collaborate on research led by Harvard immunologist Arlene Sharpe seeking to identify new pathways for the treatment of cancer. Under the terms of the agreement with Harvard’s Office of Technology Development, Merck will have the option to...
MD Anderson Inks a strategic partnership with Poland memorializing an agreement to share new technologies in cancer treatment. The deal was signed by Polish Minister of Health Lukasz Szumowski and MD Anderson of University of Texas. Polish President Andrzej Duda and...
Major academic centers such as Columbia University capitalize on opportunity to form drug development partnerships directly private equity Investors such as Deerfield Columbia University will partner with Deerfield Management to form a drug research and development...
Sara Gilgore of Washington Business Journal reports that Gaithersburg-based Viela Bio Inc., has secured a $220 million agreement with Hansoh Pharmaceutical Group. The two have come together so that Hansoh can commercialize Viela’s lead candidate in China. Partnership...
France-based Transgene (TNG) a biotech venture that designs and develops virus-based immunotherapies against cancers and infectious diseases announced the inking of deal with global UK pharma AstraZeneca. The two have inked a collaborative research, option and...
